NCT06449170

Brief Summary

To determine diet-health associations, researchers rely on information obtained from dietary instruments, such as the 24-hour recall (R24H), food frequency questionnaires (FFQ) and food diaries, in clinical studies. However, it is widely recognized that the information provided by the different instruments is biased by different factors including recall errors and respondent burden. The impact of the variability produced by this bias decreases the robustness of diet-health associations which results in the creation of less efficient standards and recommendations for our population. To address this, the discovery of biomarkers of food intake (BFIs) is an objective tool that indicates exposure to specific foods or various dietary patterns. BFIs allow the calibration of dietary information to obtain the real consumption of the individual and thus clarify the relationship between different pathologies of interest and the intake of different foods. BIAMEX will initially focus on the discovery of BFIs of nopal, corn tortilla, mango, avocado, guava and amaranth. For this purpose, a controlled crossover intervention study is being carried out with the 6 foods to be investigated where 24h urine and plasma samples are being collected. Subsequently, the samples collected will be analyzed by mass spectrometry.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2023

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 5, 2024

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

May 22, 2024

Completed
16 days until next milestone

First Posted

Study publicly available on registry

June 7, 2024

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

June 7, 2024

Status Verified

June 1, 2024

Enrollment Period

1.3 years

First QC Date

May 22, 2024

Last Update Submit

June 6, 2024

Conditions

Keywords

metabolomicsnutritiondietary biomarkersdietary exposure

Outcome Measures

Primary Outcomes (2)

  • Metabolic profiling of urine samples after intake of mango, amaranth, nopal, corn tortilla, avocado, and guava, detected as mass-to-charge signals (cps) by an untargeted metabolomics approach over 24 hours post-intake.

    Given the absence of a priori knowledge of specific urinary biomarkers of intake for mango, nopal, amaranth, avocado, corn tortilla, and guava, an untargeted metabolomics approach will be employed to identify them. As an exploratory approach, this methodology will determine the myriad of signals (mass-to-charge ratios) present in urine samples, which correspond to metabolites that become bioavailable after the intake of the test foods, collected at 0-1, 1-2, 4-6, 6-12, and 12-24 hours after intake. The analysis of the patterns in the metabolome will facilitate the discovery of potential biomarkers of intake.

    Before intake of foods 00 hours to 24 hours after intake.

  • Metabolic profiling of serum samples after intake of mango, amaranth, nopal, corn tortilla, avocado, and guava, detected as mass-to-charge signals (cps) by an untargeted metabolomics approach over 24 hours post-intake.

    Given the absence of a priori knowledge of specific serum biomarkers of intake for mango, nopal, amaranth, avocado, corn tortilla, and guava, an untargeted metabolomics approach will be employed to identify them. As an exploratory approach, this methodology will determine the myriad of signals (mass-to-charge ratios) present in serum samples collected at baseline, 1 hour, 2 hours, 4 hours, 6 hours, and 24 hours after the intake of. The analysis of the patterns in the metabolome will facilitate the discovery of potential biomarkers of intake.

    Before intake of foods 00 hours to 24 hours after intake.

Study Arms (7)

Mango Ataulfo

OTHER

150g of mango Ataulfo plus 150 ml of control beverage (Supportan® Drink Cappuccino) plus 15ml of sunflower seed oil

Other: Mango Ataulfo

Avocado Hass

OTHER

120g of avocado hass plus 150ml of control beverage (Supportan® Drink Cappuccino)

Other: Avocado Hass

Boiled Nopal

OTHER

300g of boiled nopal plus 150 ml of control beverage (Supportan® Drink Cappuccino) plus 18ml of sunflower seed oil

Other: Nopal

Corn Tortilla

OTHER

3 pieces of corn tortilla plus 150 ml of control beverage (Supportan® Drink Cappuccino) plus 2ml of sunflower seed oil

Other: 3 corn tortilla

Guava

OTHER

3 pieces of guava plus 150 ml of control beverage (Supportan® Drink Cappuccino) plus 16ml of sunflower seed oil

Other: Guava

Amaranth

OTHER

1/2 cup of amaranth plus 150 ml of control beverage (Supportan® Drink Cappuccino) plus 35ml of sunflower seed oil

Other: Amaranth

Supportan® DKN Cappuccino

OTHER

290ml of control beverage (Supportan® Drink Cappuccino)

Dietary Supplement: Control Beverage (Supportan Drink ® Capuccino)

Interventions

In this intervention, subjects consumed 150g of mango Ataulfo plus 150 ml of control beverage (Supportan® Drink Cappuccino). The addition of the control beverage has the purpose of providing energy intake and limiting the noise that the control beverage may contribute to the metabolomic profile in urine and serum.

Mango Ataulfo

In this intervention, subjects consumed 120g of avocado hass plus 150 ml of a control beverage (Supportan® Drink Cappuccino). The addition of the control beverage provides energy intake and limits the noise that the beverage may contribute to the metabolomic profile in urine and serum.

Avocado Hass
NopalOTHER

In this intervention, subjects consumed 300g of cooked nopal and 150 ml of control beverage (Supportan® Drink Cappuccino). The addition of the control beverage provides energy intake and limits the noise that the beverage may contribute to the metabolic profile in urine and serum.

Boiled Nopal

In this intervention, subjects consumed 3 corn tortillas and 150 ml of control beverage (Supportan® Drink Cappuccino). The addition of the control beverage provides energy intake and limits the noise that the beverage may contribute to the metabolic profile in urine and serum.

Corn Tortilla
GuavaOTHER

In this intervention, subjects consumed 3 guavas and 150 ml of control beverage (Supportan® Drink Cappuccino). The addition of the control beverage provides energy intake and limits the noise that the beverage may contribute to the metabolic profile in urine and serum.

Guava

In this intervention, subjects consumed 1/2 cup of amaranth and 150 ml of control beverage (Supportan® Drink Cappuccino). The addition of the control beverage provides energy intake and limits the noise that the beverage may contribute to the metabolic profile in urine and serum.

Amaranth

In this intervention, subjects consumed 290ml of Supportan Drink ® Capuccino to act as a control for the metabolomic profiling in urine and serum.

Supportan® DKN Cappuccino

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Signed informed consent
  • Healthy males and females
  • BMI \>18.5 and \< 25 kg/m2
  • Willing/able to consume all test foods and the standardized meals

You may not qualify if:

  • Smokers
  • Diagnosed health condition (chronic or infectious disease)
  • Taking nutritional supplements (e.g. vitamins, minerals) several times a week.
  • Taking medication.
  • Pregnant, lactating.
  • Antibiotics treatment within 3 months prior to intervention.
  • Vegetarians, as standardized meals will contain meat.
  • Not willing to follow nutritional restrictions, including drinking alcohol during study days
  • Allergic to foods of interest

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Instituto de Ciencias Médicas y Nutrición Salvador Zubirán

Mexico City, 14080, Mexico

Location

Related Publications (27)

  • Archer E, Marlow ML, Lavie CJ. Controversy and debate: Memory-Based Methods Paper 1: the fatal flaws of food frequency questionnaires and other memory-based dietary assessment methods. J Clin Epidemiol. 2018 Dec;104:113-124. doi: 10.1016/j.jclinepi.2018.08.003. Epub 2018 Aug 17.

    PMID: 30121379BACKGROUND
  • Tinker LF, Sarto GE, Howard BV, Huang Y, Neuhouser ML, Mossavar-Rahmani Y, Beasley JM, Margolis KL, Eaton CB, Phillips LS, Prentice RL. Biomarker-calibrated dietary energy and protein intake associations with diabetes risk among postmenopausal women from the Women's Health Initiative. Am J Clin Nutr. 2011 Dec;94(6):1600-6. doi: 10.3945/ajcn.111.018648. Epub 2011 Nov 9.

    PMID: 22071707BACKGROUND
  • Vanderslice JT, Higgs DJ. Vitamin C content of foods: sample variability. Am J Clin Nutr. 1991 Dec;54(6 Suppl):1323S-1327S. doi: 10.1093/ajcn/54.6.1323s.

    PMID: 1962591BACKGROUND
  • Andersen MB, Kristensen M, Manach C, Pujos-Guillot E, Poulsen SK, Larsen TM, Astrup A, Dragsted L. Discovery and validation of urinary exposure markers for different plant foods by untargeted metabolomics. Anal Bioanal Chem. 2014 Mar;406(7):1829-44. doi: 10.1007/s00216-013-7498-5. Epub 2014 Jan 4.

    PMID: 24390407BACKGROUND
  • Gibbons H, Michielsen CJR, Rundle M, Frost G, McNulty BA, Nugent AP, Walton J, Flynn A, Gibney MJ, Brennan L. Demonstration of the utility of biomarkers for dietary intake assessment; proline betaine as an example. Mol Nutr Food Res. 2017 Oct;61(10). doi: 10.1002/mnfr.201700037. Epub 2017 Jul 20.

    PMID: 28556565BACKGROUND
  • Cuparencu C, Rinnan A, Dragsted LO. Combined Markers to Assess Meat Intake-Human Metabolomic Studies of Discovery and Validation. Mol Nutr Food Res. 2019 Sep;63(17):e1900106. doi: 10.1002/mnfr.201900106. Epub 2019 Jun 13.

    PMID: 31141834BACKGROUND
  • Vazquez-Manjarrez N, Weinert CH, Ulaszewska MM, Mack CI, Micheau P, Petera M, Durand S, Pujos-Guillot E, Egert B, Mattivi F, Bub A, Dragsted LO, Kulling SE, Manach C. Discovery and Validation of Banana Intake Biomarkers Using Untargeted Metabolomics in Human Intervention and Cross-sectional Studies. J Nutr. 2019 Oct 1;149(10):1701-1713. doi: 10.1093/jn/nxz125.

    PMID: 31240312BACKGROUND
  • Giesbertz P, Brandl B, Lee YM, Hauner H, Daniel H, Skurk T. Specificity, Dose Dependency, and Kinetics of Markers of Chicken and Beef Intake Using Targeted Quantitative LC-MS/MS: A Human Intervention Trial. Mol Nutr Food Res. 2020 Mar;64(5):e1900921. doi: 10.1002/mnfr.201900921. Epub 2020 Jan 29.

    PMID: 31916678BACKGROUND
  • Ulaszewska MM, Weinert CH, Trimigno A, Portmann R, Andres Lacueva C, Badertscher R, Brennan L, Brunius C, Bub A, Capozzi F, Cialie Rosso M, Cordero CE, Daniel H, Durand S, Egert B, Ferrario PG, Feskens EJM, Franceschi P, Garcia-Aloy M, Giacomoni F, Giesbertz P, Gonzalez-Dominguez R, Hanhineva K, Hemeryck LY, Kopka J, Kulling SE, Llorach R, Manach C, Mattivi F, Migne C, Munger LH, Ott B, Picone G, Pimentel G, Pujos-Guillot E, Riccadonna S, Rist MJ, Rombouts C, Rubert J, Skurk T, Sri Harsha PSC, Van Meulebroek L, Vanhaecke L, Vazquez-Fresno R, Wishart D, Vergeres G. Nutrimetabolomics: An Integrative Action for Metabolomic Analyses in Human Nutritional Studies. Mol Nutr Food Res. 2019 Jan;63(1):e1800384. doi: 10.1002/mnfr.201800384. Epub 2018 Oct 11.

    PMID: 30176196BACKGROUND
  • Dragsted LO, Gao Q, Scalbert A, Vergeres G, Kolehmainen M, Manach C, Brennan L, Afman LA, Wishart DS, Andres Lacueva C, Garcia-Aloy M, Verhagen H, Feskens EJM, Pratico G. Validation of biomarkers of food intake-critical assessment of candidate biomarkers. Genes Nutr. 2018 May 30;13:14. doi: 10.1186/s12263-018-0603-9. eCollection 2018.

    PMID: 29861790BACKGROUND
  • Barnes RC, Krenek KA, Meibohm B, Mertens-Talcott SU, Talcott ST. Urinary metabolites from mango (Mangifera indica L. cv. Keitt) galloyl derivatives and in vitro hydrolysis of gallotannins in physiological conditions. Mol Nutr Food Res. 2016 Mar;60(3):542-50. doi: 10.1002/mnfr.201500706. Epub 2016 Feb 2.

    PMID: 26640139BACKGROUND
  • Kim H, Castellon-Chicas MJ, Arbizu S, Talcott ST, Drury NL, Smith S, Mertens-Talcott SU. Mango (Mangifera indica L.) Polyphenols: Anti-Inflammatory Intestinal Microbial Health Benefits, and Associated Mechanisms of Actions. Molecules. 2021 May 6;26(9):2732. doi: 10.3390/molecules26092732.

    PMID: 34066494BACKGROUND
  • Ferreira CM, Vieira AT, Vinolo MA, Oliveira FA, Curi R, Martins Fdos S. The central role of the gut microbiota in chronic inflammatory diseases. J Immunol Res. 2014;2014:689492. doi: 10.1155/2014/689492. Epub 2014 Sep 18.

    PMID: 25309932BACKGROUND
  • Dreher ML, Davenport AJ. Hass avocado composition and potential health effects. Crit Rev Food Sci Nutr. 2013;53(7):738-50. doi: 10.1080/10408398.2011.556759.

    PMID: 23638933BACKGROUND
  • Fulgoni VL 3rd, Dreher M, Davenport AJ. Avocado consumption is associated with better diet quality and nutrient intake, and lower metabolic syndrome risk in US adults: results from the National Health and Nutrition Examination Survey (NHANES) 2001-2008. Nutr J. 2013 Jan 2;12:1. doi: 10.1186/1475-2891-12-1.

    PMID: 23282226BACKGROUND
  • Vazquez-Manjarrez N, Ulaszewska M, Garcia-Aloy M, Mattivi F, Pratico G, Dragsted LO, Manach C. Biomarkers of intake for tropical fruits. Genes Nutr. 2020 Jun 19;15(1):11. doi: 10.1186/s12263-020-00670-4.

    PMID: 32560627BACKGROUND
  • Qin XJ, Yu Q, Yan H, Khan A, Feng MY, Li PP, Hao XJ, An LK, Liu HY. Meroterpenoids with Antitumor Activities from Guava (Psidium guajava). J Agric Food Chem. 2017 Jun 21;65(24):4993-4999. doi: 10.1021/acs.jafc.7b01762. Epub 2017 Jun 9.

    PMID: 28578580BACKGROUND
  • Kohlert C, van Rensen I, Marz R, Schindler G, Graefe EU, Veit M. Bioavailability and pharmacokinetics of natural volatile terpenes in animals and humans. Planta Med. 2000 Aug;66(6):495-505. doi: 10.1055/s-2000-8616.

    PMID: 10985073BACKGROUND
  • Pujos-Guillot E, Hubert J, Martin JF, Lyan B, Quintana M, Claude S, Chabanas B, Rothwell JA, Bennetau-Pelissero C, Scalbert A, Comte B, Hercberg S, Morand C, Galan P, Manach C. Mass spectrometry-based metabolomics for the discovery of biomarkers of fruit and vegetable intake: citrus fruit as a case study. J Proteome Res. 2013 Apr 5;12(4):1645-59. doi: 10.1021/pr300997c. Epub 2013 Mar 5.

    PMID: 23425595BACKGROUND
  • Lopez-Romero P, Pichardo-Ontiveros E, Avila-Nava A, Vazquez-Manjarrez N, Tovar AR, Pedraza-Chaverri J, Torres N. The effect of nopal (Opuntia ficus indica) on postprandial blood glucose, incretins, and antioxidant activity in Mexican patients with type 2 diabetes after consumption of two different composition breakfasts. J Acad Nutr Diet. 2014 Nov;114(11):1811-8. doi: 10.1016/j.jand.2014.06.352. Epub 2014 Aug 12.

    PMID: 25132122BACKGROUND
  • Vazquez-Manjarrez N, Guevara-Cruz M, Flores-Lopez A, Pichardo-Ontiveros E, Tovar AR, Torres N. Effect of a dietary intervention with functional foods on LDL-C concentrations and lipoprotein subclasses in overweight subjects with hypercholesterolemia: Results of a controlled trial. Clin Nutr. 2021 May;40(5):2527-2534. doi: 10.1016/j.clnu.2021.02.048. Epub 2021 Mar 6.

    PMID: 33932799BACKGROUND
  • Nkobole N, Prinsloo G. 1H-NMR and LC-MS Based Metabolomics Analysis of Wild and Cultivated Amaranthus spp. Molecules. 2021 Feb 4;26(4):795. doi: 10.3390/molecules26040795.

    PMID: 33557008BACKGROUND
  • Warrack BM, Hnatyshyn S, Ott KH, Reily MD, Sanders M, Zhang H, Drexler DM. Normalization strategies for metabonomic analysis of urine samples. J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Feb 15;877(5-6):547-52. doi: 10.1016/j.jchromb.2009.01.007. Epub 2009 Jan 14.

    PMID: 19185549BACKGROUND
  • Kohl SM, Klein MS, Hochrein J, Oefner PJ, Spang R, Gronwald W. State-of-the art data normalization methods improve NMR-based metabolomic analysis. Metabolomics. 2012 Jun;8(Suppl 1):146-160. doi: 10.1007/s11306-011-0350-z. Epub 2011 Aug 12.

    PMID: 22593726BACKGROUND
  • Scalbert A, Brennan L, Manach C, Andres-Lacueva C, Dragsted LO, Draper J, Rappaport SM, van der Hooft JJ, Wishart DS. The food metabolome: a window over dietary exposure. Am J Clin Nutr. 2014 Jun;99(6):1286-308. doi: 10.3945/ajcn.113.076133. Epub 2014 Apr 23.

    PMID: 24760973BACKGROUND
  • van den Berg RA, Hoefsloot HC, Westerhuis JA, Smilde AK, van der Werf MJ. Centering, scaling, and transformations: improving the biological information content of metabolomics data. BMC Genomics. 2006 Jun 8;7:142. doi: 10.1186/1471-2164-7-142.

    PMID: 16762068BACKGROUND
  • Vinaixa M, Samino S, Saez I, Duran J, Guinovart JJ, Yanes O. A Guideline to Univariate Statistical Analysis for LC/MS-Based Untargeted Metabolomics-Derived Data. Metabolites. 2012 Oct 18;2(4):775-95. doi: 10.3390/metabo2040775.

    PMID: 24957762BACKGROUND

Related Links

MeSH Terms

Conditions

Feeding Behavior

Interventions

Amaranth Dye

Condition Hierarchy (Ancestors)

Behavior, AnimalBehavior

Intervention Hierarchy (Ancestors)

Azo CompoundsOrganic ChemicalsNaphthalenesulfonatesNaphthalenesPolycyclic Aromatic HydrocarbonsHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsArylsulfonatesArylsulfonic AcidsSulfonic AcidsSulfur AcidsSulfur CompoundsPolycyclic Compounds

Study Officials

  • Natalia Vázquez Manjarrez, PhD

    National Institute of Medical Sciences and Nutrition Salvador Zubirán

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Model Details: This is a randomized, open, crossover, and controlled design study. A total of 12 healthy subjects (six males and six females) aged 18-40 years with a BMI of 18.5-24.9 kg/m\^2 were recruited. Participants underwent seven interventions (each featuring one of the selected foods or a control beverage), with a washout period of 7 days between interventions. Each intervention is as follows: 150g of mango + 150ml of control beverage, 120g of avocado + 150ml of control beverage, 300g of cooked nopal + 150ml of control beverage, 3 corn tortillas + 150ml of control beverage, 3 guavas + 150ml of control beverage, ½ cup of amaranth + 150ml of control beverage, 290ml of control beverage
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Researcher in Medical Sciences

Study Record Dates

First Submitted

May 22, 2024

First Posted

June 7, 2024

Study Start

January 1, 2023

Primary Completion

April 5, 2024

Study Completion

December 31, 2024

Last Updated

June 7, 2024

Record last verified: 2024-06

Locations